Curatio synergies, product launches key for Torrent Pharma
However, the company’s March quarter (Q4FY23) results are broadly in line with Street estimates. Analysts say stable margin last quarter, expected gains from Curatio integration and new product launches are reasons for optimism.
Prabhudas Lilladher Param Desai View Full Image Institutional Securities Pharma Results Acquisition Torrent Pharmaceuticals Ltd
Source: livemint.com